Study ID: Emory University MILES Knee Osteoarthritis Study


Randomized multicenter phase 3 single-blind trial comparing the efficacy of corticosteroid control to mesenchymal stem cell preparations from autologous bone marrow concentrate (BMAC), adipose derived stem cells in the form of Stromal Vascular Fraction (SVF), and third party human mesenchymal stem cells manufactured from umbilical cord tissue for the treatment of unilateral Knee Osteoarthritis (OA).

Title: Multicenter trIal of stem ceLl thErapy for oSteoarthritis (MILES). Description: Multicenter trIal of stem ceLl thErapy for oSteoarthritis (MILES). 4 Key Inclusion/Exclusion Criteria including Age Range If Applicable: 1. Confirmed diagnosis of Knee Osteoarthritis on recent x-ray of grade II – grade IV 2. Age range between 40-70 years old, male and female 3. Consistent pain that averages at least a 3 out of a 1-10 scale 4. Continued OA pain despite other treatment such as viscosupplementation, corticosteroid injections, and PRP
Fargo Region, Sanford Health, Sioux Falls Region
Principal Investigator:
Chad Kurtenbach, MD,Ben Noonan
Bones and Joints
Phase III
Active - Open to Accrual